Pancreatic cancer trials in Finland

In Finland 13 Also abroad 1095

13 trials · From ClinicalTrials.gov and EU CTIS (euclinicaltrials.eu), checked 10 November 2026. Ask the study team whether a trial fits you.

Phase 1/2Taking people
A 2-part Phase 1/2 Open-label Trial on ODM-212
Where
Helsinki, Turku
Age
18 years and over
People
229 worldwide
Run by
Orion Corporation, Orion Pharma
See details and how to joinNCT07563738
Phase 3Taking people
A Study to Evaluate Chemotherapy With or Without INCB161734 in Previously Untreated, KRAS G12D-Mutated Metastatic Pancreatic Ductal Adenocarcinoma
Where
HUS, Tampere, Turku
Age
18 years and over
People
588 worldwide
Run by
Incyte Corporation
See details and how to joinNCT07522073
Phase 1/2Taking people
A Study to Test the Safety and Effectiveness of GSK5764227, Alone or With Other Treatments, in Participants With Advanced Gastrointestinal Cancers That Cannot be Surgically Removed (EMBOLD PanGI-201)
Where
Helsinki, Kuopio, Tampere
Age
18 years and over
People
346 worldwide
Run by
GlaxoSmithKline
See details and how to joinNCT06885034
Phase 3Taking people
A clinical trial of belzutifan and other treatments in people with solid tumors or von Hippel-Lindau (VHL)-related tumors (MK-6482-043)
Where
Helsinki, Tampere
Age
18 years and over
People
134 worldwide
Run by
Merck Sharp & Dohme LLC
See details and how to join2025-524160-38-00 · EU 2025-524160-38-00
Phase 3Taking people
A Randomized, Double-Blind, Phase 3 Study of Chemotherapy With or Without INCB161734 in Previously Untreated, KRAS G12D–Mutated Metastatic Pancreatic Ductal Adenocarcinoma (DAWN-303)
Where
Helsinki, Tampere, Turku
Age
18 years and over
People
239 worldwide
Run by
Incyte Corp.
See details and how to join2025-525009-18-00 · EU 2025-525009-18-00
No phaseTaking people
A Pan-European Post-Authorisation Safety Study: Risk of Pancreatic Cancer Among Type 2 Diabetes Patients Who Initiated Exenatide as Compared With Those Who Initiated Other Non-Glucagon-Like Peptide 1 Receptor Agonists Based Glucose Lowering Drugs
Where
Helsinki
Age
18 years to 99 years
People
24,000 worldwide
Run by
AstraZeneca
See details and how to joinNCT05663515
Phase 4Taking people
Preventing postoperative complications in patients undergoing high-risk pancreatoduodenectomy with a bundle approach including hydrocortisone, ocreotide, and teres ligament patch (PANENCA): an international randomized controlled multicenter trial
Where
Helsinki
Age
18 years and over
People
460 worldwide
Run by
Amsterdam UMC Stichting
See details and how to join2024-519667-18-00 · EU 2024-519667-18-00
Phase 3Taking people
Intensified treatment in patients with oligometastatic pancreatic cancer - multimodal surgical treatment versus systemic chemotherapy alone: a randomized controlled trial - METAPANC
Where
Helsinki
Age
18 years and over
People
500 worldwide
Run by
Universitaetsmedizin Goettingen
See details and how to join2023-503558-10-00 · EU 2023-503558-10-00
Phase 3Not yet taking people in Finland
Neoadjuvant Treatment vs Upfront Surgery for Left-Sided Pancreatic Cancer
Where
Helsinki, Oulu
Age
18 years to 85 years
People
381
Run by
Helsinki University Central Hospital
See details and how to joinNCT07155629
Phase 2/3Taking people
Pancreatic Cancer Diagnosis With FAPI-PET Imaging
Where
Turku
Age
18 years to 85 years
People
100
Run by
Turku University Hospital
See details and how to joinNCT07098598
Phase 4Taking people
Pre- Vs. Postoperative Thromboprophylaxis in Pancreatic Surgery
Where
Helsinki, Oulu, Tampere
Age
18 years to 120 years
People
800 worldwide
Run by
Helsinki University Central Hospital
See details and how to joinNCT05245877
Phase 4Taking people
Prevention of thromboembolism during pancreatic cancer treatments - link to prognosis and relapse of the disease.
Where
Helsinki, Oulu, Tampere, Turku
Age
18 years and over
People
214
Run by
HUS-Yhtymae
See details and how to join2024-512475-12-01 · EU 2024-512475-12-01
Phase 2Taking people
Diagnostic Efficacy of 18F-FAPI-74 PET/CT in Patients with Pancreatic Cancer
Where
Turku
Age
18 years and over
People
100
Run by
Turku University Hospital
See details and how to join2023-510208-39-00 · EU 2023-510208-39-00